Clin2
NCT07635368Possibly a fitRecruiting

Blood Markers in Newborns With CMV Infection

Congenital CytomegalovirusCytomegalovirus InfectionsNeonatal InfectionSensorineural Hearing LossViral Infection

Part of Brain & nervous system, Ear, nose & throat, Infections clinical trials.

This research study examines blood samples from newborns to identify biological markers (proteins and genetic signals) that could help detect and understand congenital cytomegalovirus (CMV) infection—a virus some babies are born with. Finding these markers might help doctors identify infected infants earlier and develop better treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
630 people
Ages
birth to 4 weeks
Study type
Observational

Who can take part

  • Your child was born between January 2010 and December 2025
  • A newborn blood screening sample (dried blood spot) was collected for your child through Denmark's national newborn screening program
  • Your child either has a confirmed CMV infection diagnosed from newborn screening blood or urine tests, OR is a healthy control child matched to an infected child by sex, gestational age, and birthweight
  • The stored blood sample has been approved by the hospital for research use
  • The blood sample contains enough material for laboratory testing of proteins and genetic expression

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06226558Recruiting
Long-Term Health of Children with Congenital CMV in NY

This study will follow children born in New York State who were tested for cytomegalovirus (CMV) as newborns. It aims to understand their long-term health and development, whether they were confirmed to have CMV, a false positive, or even a late detection if born early.

Stony Brook, New York
NCT07860580Recruiting
Blood markers in children with congenital hearing loss

This study looks at certain substances in the blood of children with congenital hearing loss (hearing loss present from birth) to see if they are different from children with normal hearing. It may help doctors understand why hearing loss happens and could lead to better treatments.

Sanliurfa
NCT06694428Recruiting
Testing a software tool for CMV blood test results in pregnancy

This trial is testing a computer program that helps doctors interpret blood test results for CMV infection in pregnant women. If you are pregnant and have had a CMV blood test, this study may help doctors better understand your results.

Limoges
NCT07210242Not yet recruiting
Monitoring for cytomegalovirus after stem cell transplant

This study looks at how well a new blood test detects cytomegalovirus (a common virus) in people who have had a stem cell transplant. The test may help doctors catch the virus early and treat it faster.

NCT05855889Recruiting
Study of care for babies with congenital CMV infection

This is an observational study that looks at how babies with congenital CMV infection are diagnosed and managed in real life. It may help doctors understand which care approaches are used and how they relate to outcomes over time.

London
NCT07335874Recruiting
Hearing screening follow-up for congenital infection in newborns

This study checks if babies who fail their newborn hearing test might have a hidden infection from birth. It looks for cytomegalovirus (CMV), a common virus that can affect hearing, using a simple test.

Strasbourg

Hear when a new Cytomegalovirus Infections trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.